Obstetrics & Gynecology Ultrasound Devices Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (2D Ultrasound, 3D/4D Ultrasound), By Portability (Cart/Trolley-Based, Portable/Handheld), By End Use, By Region, And Segment Forecasts

Obstetrics & Gynecology Ultrasound Devices Market Summary

In addition, the increasing demand for advanced diagnostic technologies in women's healthcare further fuels the market's growth. Technological advancements, such as 3D/4D imaging and high-resolution image quality, improve diagnostic accuracy and visualization of fetal anatomy. These systems allow healthcare professionals to monitor and assess the health of pregnant women, providing crucial information on fetal development, placental health, and potential complications. As awareness grows regarding the importance of early detection and prevention of gynecological and obstetric conditions, the demand for ultrasound systems with improved imaging capabilities and advanced features continues to grow. This is further supported by the increasing emphasis on prenatal care and fetal health monitoring, with ultrasound devices playing a crucial role in prenatal screenings to ensure the well-being of pregnant women.

Technological advancements in ultrasound technology significantly contribute to the growth of the OB-GYN ultrasound systems industry. Innovations such as high-resolution image quality, 3D/4D imaging, and advanced software features enhance diagnostic accuracy and provide better visualization of fetal anatomy and maternal structures. For instance, in October 2024, GE Healthcare launched the Versana Premier ultrasound system. It offers AI-enabled tools to enhance workflow, clinical efficiency, and accuracy. It's designed for diverse specialties, such as OB-GYN and cardiology, with various features, including Whizz for real-time image optimization and AI-powered labeling. The Versana Premier provides high-quality imaging and aims for simplified diagnostics. Such advancements enable more precise and detailed assessments, improving the ability to detect abnormalities and ensure appropriate treatment and management.

The obstetrics & gynecology ultrasound devices industry growth is also fueled by the increasing healthcare expenditure in developing countries, leading to the establishment of new hospitals and medical centers. For instance, in November 2024, New Mexico announced an investment of USD 5.4 million in rural health, with significant funds allocated for maternal care. Multicultural Evaluation and Consultation Associates, LLC is expected to receive USD 1.6 million to enhance maternal health coordination in Doña Ana, Curry, Lea, Chaves, Quay, and Roosevelt counties. The initiative addresses the unique challenges faced by rural communities in accessing quality healthcare. Such investment and expansion of healthcare infrastructure for maternal care creates significant opportunities for market growth.

Market Concentration & Characteristics

The obstetrics & gynecology ultrasound devices industry is accelerating at a significant rate, driven by the rising prevalence of gynecological and obstetric conditions, including uterine fibroids, ovarian cysts, and high-risk pregnancies, driving the demand for timely and precise diagnoses. Technological developments, such as 3D/4D imaging and enhanced image resolution, contribute to improved diagnostic precision and visualization of fetal anatomy. The growing requirement for advanced diagnostic technologies in women's healthcare is also contributing to market growth.

The degree of innovation is significantly high in the Obstetrics & Gynecology (OB/GYN) ultrasound devices industry due to the continuous integration of advanced technologies that improve diagnostic precision and expand the scope of applications. Innovations such as 3D and 4D imaging provide detailed visualization of fetal anatomy, helping in the early detection of congenital anomalies. The integration of Artificial Intelligence (AI) algorithms enhances image analysis, automates measurements, and assists clinicians in identifying potential concerns more efficiently. Furthermore, the development of portable and point-of-care ultrasound systems allows real-time diagnostic imaging at the patient's bedside, which is crucial for quick decision-making during emergencies and in primary care settings.

The market players are adopting mergers and acquisitions as a strategic approach to increase their market presence and product portfolios, thereby driving market growth. For instance, in January 2025, Hologic announced the acquisition of Gynesonics, developer of the Sonata System, an FDA-cleared ultrasound device for fibroid diagnosis and treatment. This purchase expands Hologic's offerings for women's health.

Regulations significantly impact the market for obstetrics & gynecology ultrasound devices by ensuring safety and effectiveness. The implementation of pre-market approval processes, such as the FDA's 510(k) pathway, establishes guidelines for ultrasound equipment, influencing the design and manufacturing of these devices. Manufacturers need to comply with the standards set by different regulatory authorities to gain device clearance, which affects the availability and types of ultrasound devices offered in the market. This regulatory oversight aims to balance innovation with patient safety, shaping the evolution and application of ultrasound technology in obstetrics and gynecology.

Companies in the market are launching innovative products to increase their product portfolio and presence in the market. Furthermore, launching innovative products allows companies to address different patient needs. For instance, in January 2025, Samsung introduced the Z20, an AI-powered ultrasound system for advanced obstetrics and gynecology applications. Launched at the Society for Maternal-Fetal Medicine conference, the Z20 features Live ViewAssist, which automates the identification of 39 views, labels up to 47 anatomical structures, and performs 46 essential measurements, enhancing diagnostic accuracy and workflow efficiency.

The market is witnessing significant growth across various regions due to high demand for routine pregnancy scans, a rising prevalence of gynecological diseases, and product innovations such as 3D and 4D ultrasound systems. Rising government initiatives and increased product launches also contribute to market growth in various regions. Moreover, developing regions, such as the Asia-Pacific region, are expected to witness significant market growth fueled by an increasing geriatric population with chronic disorders, improvements in healthcare infrastructure, and rising emphasis on early diagnosis and treatment.

Product Insights

The 3D/4D ultrasound segment dominated the market and accounted for the largest revenue share of 41.5% in 2024. This can be attributed to the increasing demand for advanced fetal imaging and improved diagnostic accuracy. Portable and handheld 3D/4D ultrasound devices are also witnessing significant demand, expanding accessibility in remote and resource-limited areas. Moreover, the technological advancements and development of advanced 3D/4D ultrasound further contribute to the segment growth. For instance, in June 2021, Mindray launched Nuewa I9, an advanced OB/GYN diagnostic ultrasound system designed to enhance women’s and neonatal healthcare. Featuring a compact, foldable design, the system integrates the ZST+ platform for superior imaging, an intelligent iConsole control panel, and Smart Scene 3D for improved diagnostic accuracy and workflow efficiency.

The 2D ultrasound segment is expected to grow at the fastest CAGR of 5.4% over the forecast period, owing to its essential role in routine prenatal screening and maternal-fetal assessments. In addition, the affordability and widespread availability of 2D ultrasound systems increase their accessibility and adoption in both high-resource and low-resource healthcare settings. Moreover, the increasing adoption of portable and handheld 2D ultrasound devices in outpatient and remote care settings further accelerates growth, enabling broader access to essential obstetric imaging globally.

Portability Insights

The cart/trolley-based ultrasound segment dominated the market and accounted for the largest revenue share in 2024. This can be attributed to their enhanced workflow efficiency. Moreover, these ultrasound systems have robust hardware and extended operational capabilities, which are essential in high-volume obstetrics and gynecology settings. They integrate seamlessly with hospital networks, ensuring instant data transfer. Furthermore, their user-friendly design, with height-adjustable consoles and wheeled mobility, allows easy movement within examination rooms while providing stability during procedures enhancing diagnostic accuracy in prenatal and gynecological evaluations.

The portable/handheld ultrasound segment is expected to grow at the fastest CAGR over the forecast period, owing to its increasing adoption in point-of-care and remote healthcare settings. Their wireless connectivity and compatibility with smartphones and tablets allow instant image sharing and telemedicine consultations, which is crucial for improving maternal care in rural or underserved areas. In addition, the increasing R&D and investments for the development of more advanced portable/handheld ultrasound systems further contribute to market growth. For instance, in November 2023, Philips secured an additional round of funding from the Bill & Melinda Gates Foundation, bringing the total investment to USD 60 million. This funding aims to enhance AI-guided capabilities in Philips' Lumify Handheld Ultrasound, simplifying prenatal scans for midwives and improving maternal health in underserved regions.

End Use Insights

The hospitals segment held the largest revenue share of 42.2% in 2024, owing to its ability to offer comprehensive maternal-fetal care, advanced diagnostic capabilities, and multidisciplinary offerings. Hospitals also handle a high volume of obstetric and gynecologic procedures, including labor and delivery, where real-time ultrasound imaging is crucial for fetal positioning, amniotic fluid evaluation, and guiding interventions. Furthermore, the rising patient pool and increasing rise in number of hospitals offering women's healthcare services are further contributing to the segment growth.

The diagnostic centers segment is expected to witness the fastest CAGR over the forecast period. This can be attributed to the rising preference for outpatient services and cost-effective imaging solutions. These centers offer specialized ultrasound examinations, including fetal anomaly scans, Doppler studies, and early pregnancy assessments, without the extended wait times associated with alternative healthcare facilities. Furthermore, the expansion of diagnostic centers in urban and semi-urban areas enhances access to obstetric and gynecological ultrasound services, thereby contributing to the growth of the segment.

Regional Insights

North America obstetrics & gynecology ultrasound devices market held the largest global share of 29.2% in 2024, driven by increasing maternal age, rising prevalence of gynecological disorders, and advancements in imaging technology. The market benefits from expanding prenatal screening programs and rising awareness of fetal health monitoring. In addition, the demand for portable ultrasound systems is growing due to the shift toward outpatient and home-based care. The strong presence of key manufacturers and continuous product innovations further contribute to the market’s growth in the region.

U.S. Obstetrics & Gynecology Ultrasound Devices Market Trends

The U.S. obstetrics & gynecology ultrasound devices industry held the largest market share in 2024 in the North America region. This is attributed to the increasing maternal age, rising cases of high-risk pregnancies, and advancements in imaging technology. The adoption of 3D/4D ultrasound systems is accelerating due to their superior imaging capabilities for fetal monitoring and gynecological assessments. Government initiatives, such as expanded Medicaid coverage for prenatal care, support market growth. In addition, a strong presence of leading manufacturers, frequent product launches, and integration of AI in ultrasound diagnostics further contribute to the market growth.

Europe Obstetrics & Gynecology Ultrasound Devices Market Trends

Europe obstetrics & gynecology ultrasound devices industry held a significant market share in 2024. This is owing to the increasing maternal age, rising demand for advanced fetal monitoring, and government initiatives supporting prenatal care. Countries such as Germany, France, and the UK are witnessing significant market growth owing to the developed healthcare infrastructure and widespread adoption of high-resolution 3D/4D ultrasound systems. Additionally, advancements in AI-powered ultrasound diagnostics and the growing preference for portable ultrasound devices in outpatient settings contribute to market growth.

The obstetrics & gynecology ultrasound devices industry in the UK is experiencing significant growth, driven by government-funded prenatal care programs, rising maternal age, and increasing adoption of advanced ultrasound technologies. The National Health Service (NHS) provides routine ultrasound screenings, increasing demand for high-resolution 3D/4D imaging systems. Private healthcare providers are also expanding their services, increasing investments in AI-integrated ultrasound for early detection of fetal anomalies and gynecological conditions. Additionally, the growing trend of portable ultrasound use in outpatient and home care settings is fueling the market growth.

Germany obstetrics & gynecology ultrasound devices industry is driven by the increasing use of ultrasound technology in prenatal care, monitoring fetal development, and diagnosing gynecological conditions. The market is also strengthened by the rising prevalence of women's health-related diseases and patient preference for less-invasive procedures. Technological advancements, especially in 3D and 4D ultrasound imaging, have further contributed to the market's growth by offering more detailed anatomical information and improved diagnostic accuracy.

France obstetrics & gynecology ultrasound devices industry is driven by the increasing use of obstetric ultrasound technology for prenatal care, fetal monitoring, and gynecological diagnostics across French healthcare facilities. This growth is further fueled by a rising preference for less-invasive procedures coupled with technological advancements in ultrasound systems.

Asia Pacific Obstetrics & Gynecology Ultrasound Devices Market Trends

Asia Pacific obstetrics & gynecology ultrasound devices industry is expected to witness the fastest CAGR of 5.61% over the forecast period. The increasing awareness of maternal and fetal health is driving the use of ultrasound devices for prenatal screenings, ensuring the well-being of both mother and child. Improving healthcare services and rising economies in countries such as China and India are further increasing the access of these devices in the region. Additionally, government initiatives to improve healthcare infrastructure are also expected to drive market growth in the region.

China obstetrics & gynecology ultrasound devices industry is expected to grow at a significant rate over the forecast period, driven by the increasing prevalence of women-related diseases such as breast and cervical cancer, driving demand for early diagnosis and treatment. The increasing adoption of minimally invasive procedures and growing awareness of women's health issues also contribute to the market growth.

Japan obstetrics & gynecology ultrasound devices industry is significantly driven by technological advancements and rising demand for non-invasive diagnostic tools. Innovations such as 3D and 4D imaging, along with the integration of artificial intelligence, have enhanced diagnostic accuracy in prenatal and gynecological care. Additionally, the shift towards portable and handheld ultrasound devices has improved accessibility in various clinical settings, supporting the market's growth.

Latin America Obstetrics & Gynecology Ultrasound Devices Market Trends

Latin America obstetrics & gynecology ultrasound devices industry is driven by the increasing prevalence of women's health-related conditions, such as breast cancer, cervical cancer, and infertility. Countries such as Brazil and Argentina are leading this growth, with significant investments in healthcare infrastructure and a focus on improving maternal and fetal health outcomes.

Middle East & Africa Obstetrics & Gynecology Ultrasound Devices Market Trends

The Middle East & Africa obstetrics & gynecology ultrasound devices industry is driven by the rising prevalence of gynecological disorders, coupled with an increasing awareness of women's health issues. Government investments in healthcare infrastructure in countries such as the UAE and Saudi Arabia have further increased the adoption of these devices.

The Saudi Arabia obstetrics & gynecology ultrasound devices industry is experiencing notable growth, driven by the rising focus on the development of healthcare infrastructure through initiatives such as the government's Healthcare Transformation Program, part of the Vision 2030 initiative, which emphasizes modernizing healthcare infrastructure and integrating advanced medical technologies. Such initiative encourages healthcare providers to adopt state-of-the-art ultrasound devices, enhancing diagnostic capabilities and patient care.

Key Obstetrics & Gynecology Ultrasound Devices Company Insights

The leading players in the obstetrics & gynecology ultrasound devices industry are actively expanding their product portfolios through technological innovations, strategic mergers and acquisitions, and the development of advanced imaging systems. In addition, these companies are adopting partnerships and collaborations to enhance innovation and strengthen their market presence globally.

Recent Developments:

• In April 2024, GE HealthCare introduced the Voluson Signature 20 and 18 ultrasound systems, integrating AI and voice commands to enhance women's health diagnostics. Features include automatic fetal anatomy measurements, pelvic floor imaging, and fibroid mapping. The "Hey Voluson" voice command reduces exam time and keystrokes, improving workflow efficiency.

• In February 2023, Samsung introduced the HERA W10 Elite, an advanced AI-powered ultrasound system for obstetrics and gynecology. Featuring HeartAssist for automated fetal heart measurements and Advanced MV-Flow for detailed blood flow visualization, the system enhances diagnostic accuracy. It also includes a high-resolution OLED display for improved imaging.

Obstetrics & Gynecology Ultrasound Devices Market Report Scope

Global Obstetrics & Gynecology Ultrasound Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global obstetrics & gynecology ultrasound devices market report based on product, portability, end use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • 2D Ultrasound

  • 3D/4D Ultrasound

  • Doppler Ultrasound

• Portability Outlook (Revenue, USD Million, 2018 - 2030)

  • Cart/Trolley

  • Portable/Handheld

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Diagnostic Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait